Aug 13, 2020 / 12:30PM GMT
Operator
Ladies and gentlemen, welcome to Calliditas Therapeutics Q2 2020. (Operator Instructions)
Today, I am pleased to present CEO, Renee Aguiar-Lucander; CFO, Fredrik Johansson; and CSO, Johan Haggblad. Please go ahead with your meeting.
Renee Aguiar-Lucander - Calliditas Therapeutics AB(publ)-CEO
Thank you very much, and welcome to this Q2 call. I'm going to start on Page 3 and just take you through the summary of key events for this quarter, Q2.
So in June, we completed an IPO on NASDAQ Global Select Market in the U.S. The gross proceeds of the offering was $90 million. And we actually were the first ever kind of Swedish life science company to actually raise capital in an IPO on the NASDAQ Select, which we think is pretty exciting. And the process itself was there was a brief kind of like a 4-day roadshow, which now all of you who have seen what's happened in the kind of capital market due to COVID-19 has become quite the standard. The offer was multiple times that were subscribed, and we're
Q2 2020 Calliditas Therapeutics AB Earnings Call Transcript
Aug 13, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers